Results 171 to 180 of about 69,008 (285)

MicroRNA Expression in Breast Cancer Patients, an Integrative Review

Journal of Surgical Oncology, Volume 133, Issue 1, Page 31-38, January 2026.
ABSTRACT This integrative review examines the differential expression of miRNAs in breast cancer patients across various disease stages. Through analysis of 42 articles published between 2005 and 2023, the review identifies multiple miRNAs with significant diagnostic, prognostic, and predictive potential in breast cancer management.
Larissa Fernanda Campos Moreira da Silva, Fabiana Pirani Carneiro, Andrea Barretto Motoyama   +2 more
wiley   +1 more source

Case Report: Pathological complete response yet early brain relapse in HER2-positive breast cancer: a case-based review. [PDF]

Front Immunol
Feng J, Tong Y, Zhang Z, He Y.
europepmc   +1 more source

Breast Cancer: Molecular Pathogenesis, Targeted Therapy, Screening, and Prevention

MedComm, Volume 7, Issue 1, January 2026.
The review manuscript examines the molecular pathogenesis, screening, prevention advances, and evolving targeted therapies in breast cancer. It highlights the integration of AI and multiomics for precision prevention and personalized treatment, pointing toward future directions in equitable cancer care.
Huijun Lei, Jinzhen Fu, Wei Gu, Hongjin Qiao, Huixue Guo, Zijian Chen, San Ming Wang, Tianhui Chen   +7 more
wiley   +1 more source

Inetetamab-Based Regimens for Patients with HER2-Positive Metastatic Breast Cancer: A Real-World Retrospective Study. [PDF]

Breast Cancer (Dove Med Press)
Chen L, Huang J, Chen X, Lan X, Song L, Xie X, Bai X, Du C.   +7 more
europepmc   +1 more source

Trastuzumab Deruxtecan in Previously Treated HER2-Low Metastatic Breast Cancer: Real-World Multicentric Study in the Portuguese Population [PDF]

Luísa Soares‐Miranda, Maria João Sousa, Miguel Martins Braga, Marisa Couto, Isabel Vieira Fernandes, Flavio Berriel Abreu, Inês Eiriz, Catarina Lopes Fernandes, Andréa Marques, Mariângela Esther Alencar Marques, Raquel Romão, Fernando Ribeiro Gonçalves, Joana Simões, António Araújo   +13 more
openalex   +1 more source

Astatine‐211—Towards In Vivo Stable Astatine‐211 Labeled Radiopharmaceuticals and Their (Pre)Clinical Applications

Medicinal Research Reviews, Volume 46, Issue 1, Page 203-237, January 2026.
ABSTRACT Targeted radioligand therapy has emerged as a promising treatment option for eradicating advanced cancer forms. α‐Emitters are considered particularly promising as they can obliterate (micro)‐metastases. The α‐emitter astatine‐211 (211At) has experienced increased interest due to its favorable decay properties.
Marius Müller, Nadia Bom Pedersen, Vladimir Shalgunov, Andreas Ingemann Jensen, Umberto Maria Battisti, Matthias Manfred Herth   +5 more
wiley   +1 more source

Tumor Heterogeneity in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer Assessed by CT Texture Analysis: Association with Survival after Trastuzumab Treatment

, 2016
Sung Hyun Yoon, Young Hoon Kim, Yoon Jin Lee, Jihoon Park, Jin Won Kim, Hye Seung Lee, Bohyoung Kim   +6 more
openalex   +2 more sources

Nanotechnology‐Enhanced Approaches for Early Cancer Diagnosis

Nano Select, Volume 7, Issue 1, January 2026.
Conventional MRI and PET provide limited sensitivity and contrast for precise brain lesion detection. In contrast, radiolabeled nanoparticlebased PET imaging enables enhanced signal specificity and sensitivity. By integrating multifunctional nanoprobes, this platform improves multimodal imaging performance, allowing more accurate visualization of ...
Jongmoo Lee, Jiyu Kim, Eunhye Cho, Junyeop Jeong, Jayeon Song, Mikyung Kang   +5 more
wiley   +1 more source

Cardiac Protective Effects of Dexrazoxane on Animal Cardiotoxicity Model Induced by Anthracycline Combined With Trastuzumab Is Associated With Upregulation of Calpain-2

, 2015
Sheng Zhang, Tingting Meng, Jingjing Liu, Xiaobei Zhang, Jin Zhang   +4 more
openalex   +1 more source

Identification of actionable targets using DEPArray‐based sorting of pure carcinoma and stromal populations from formalin‐fixed paraffin‐embedded tissues followed by shallow whole‐genome sequencing

The Journal of Pathology, Volume 268, Issue 1, Page 13-26, January 2026.
Abstract Formalin‐fixed paraffin‐embedded (FFPE) tissue specimens represent precious resources for clinical genomic profiling studies, especially when coupled with comprehensive medical records. Even though next‐generation sequencing (NGS) is an effective tool to detect somatic mutations and somatic copy number alterations (sCNA), the biggest ...
Georgios Nteliopoulos, Evie Wren, Amelia Rushton, Marc K Wadsley, Daniel Fernandez‐Garcia, Floriana Manodoro, Otis Agbaimoni, Ritika Chauhan, Zhao Cheng, Darren P Ennis, Karen Page, Rebecca C Allsopp, Joel Bautista, Ignazio Puccio, Nik Matthews, Kelly LT Gleason, Rehman Farah, Laura Kenny, Iain A McNeish, Jacqueline A Shaw, R Charles Coombes   +20 more
wiley   +1 more source